Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Exercise or conversion SVP, Corp Dev., Alkermes, Inc. acquired 5,523 shares (option exercise)
  2. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,029 shares (to pay taxes)
  4. 4 Gift SVP, CLO, Alkermes, Inc. gave 1,000 shares (gift)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Director and CEO, Alkermes plc sold 75,000 shares at $15.00 ($1,125,233)
  16. 4 Exercise or conversion SVP, Alks Inc; CFO ALKS acquired 21,983 shares (option exercise)
  17. 4 Open-market sale SVP Finance & CAO, Alks Inc. sold 6,250 shares at $15.39 ($96,193)
  18. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 18,000 shares at $15.75 ($283,469)
  19. 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at $14.63 ($731,265)
  20. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $14.06 ($351,425)

Page 20 of 67 · 1,323 filings